Evidence Synthesis
AMRAPLIN's quarterly performance shows a decline in revenue growth, with the metric 453.5% down from 810.5%.
This represents a decrease of in quarterly revenue growth. The company's daily volume has also seen a significant drop, moving from 28,028 shares to 4,355 shares, a decline of . Additionally, the close price has decreased, falling from 35.39 INR to 34.9 INR, a drop of . However, AMRAPLIN's marginal operating leverage has seen an acceleration, increasing to from 0.03%. The company's gross margin has also seen a decline, moving from 0.11% to 0.09%, representing a decrease of .